Sign In
Last checked at 
12 Dec 2025 15:00
Dr. Martens plc (the 'Company')
Director/PDMR Shareholding
Notification of Transactions by Directors/Persons Discharging Managerial Responsibility
The Company announces that it was notified on 12 December 2025 of the following transactions in the Company's Ordinary 1p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs') under the Company's Share Incentive Plan ('SIP').
The SIP is an HMRC approved, all-employee scheme under which participating employees are able to purchase shares in the Company from monthly salary ('Partnership Shares') and receive allocations of free 'Matching Shares', awarded at a rate of one Matching Share for every one Partnership Share purchased by a participating employee, from the Company.
On 11 December 2025, the following directors / PDMRs acquired Partnership Shares as a result of their participation in the SIP at a price of 76.25 pence per share and were granted an allocation of Matching Shares (for no consideration) in the quantity set out in the table below:
Director / PDMR | Number of Partnership Shares purchased | Number ofMatching Shares awarded |
Ije Nwokorie | 197 | 197 |
Giles Wilson | 197 | 197 |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||||||||||||||
a) | Name | Ije Nwokorie | ||||||||||||||||||||
2 | Reason for the notification | |||||||||||||||||||||
a) | Position/status | PDMR (Chief Executive Officer) | ||||||||||||||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||||
a) | Name | Dr. Martens plc | ||||||||||||||||||||
b) | LEI | 213800QPT8YM6NQZPH28 | ||||||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||||||||||||||||||
b) | Nature of the transaction | 1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP | ||||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||||
d) | Aggregated information
|
| ||||||||||||||||||||
e) | Date of the transaction | 11 December 2025 | ||||||||||||||||||||
f) | Place of the transaction | 1. London Stock Exchange (XLON) 2. Outside of a trading venue | ||||||||||||||||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||||||||||||||
a) | Name | Giles Wilson | ||||||||||||||||||||
2 | Reason for the notification | |||||||||||||||||||||
a) | Position/status | PDMR (Chief Financial Officer) | ||||||||||||||||||||
b) | Initial notification/Amendment | Initial notification | ||||||||||||||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||||
a) | Name | Dr. Martens plc | ||||||||||||||||||||
b) | LEI | 213800QPT8YM6NQZPH28 | ||||||||||||||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||||||||||||||||||
b) | Nature of the transaction | 1. Purchase of Partnership Shares under the SIP 2. Award of Matching Shares under the SIP | ||||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||||
d) | Aggregated information
|
| ||||||||||||||||||||
e) | Date of the transaction | 11 December 2025 | ||||||||||||||||||||
f) | Place of the transaction | 1. London Stock Exchange (XLON) 2. Outside of a trading venue | ||||||||||||||||||||
For further information please contact:
Rebecca Flaherty
Assistant Company Secretary
+44(0)7585 3982165
Follow the stocks
